The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2)
Condition(s):Cervical Intraepithelial Neoplasia Grade 2; DNA MethylationLast Updated:November 22, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Cervical Intraepithelial Neoplasia Grade 2; DNA MethylationLast Updated:November 22, 2022Recruiting
Condition(s):Cervical Intraepithelial Neoplasia; HPVLast Updated:November 19, 2018Unknown status
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:July 27, 2016Terminated
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:July 6, 2023Recruiting
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:September 4, 2015Completed
Condition(s):Cervical Intraepithelial Neoplasia Grade 2/3; High-risk HPV (Any Strain)Last Updated:April 28, 2021Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:August 16, 2018Unknown status
Condition(s):Carcinoma in Situ of Uterine Cervix; Cervical Intraepithelial Neoplasias; High Grade Cervical Intraepithelial NeoplasiaLast Updated:April 10, 2015Unknown status
Condition(s):Cervical DysplasiaLast Updated:March 29, 2017Completed
Condition(s):Cervical Intraepithelial NeoplasiaLast Updated:February 6, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.